Elevance Health Inc (0HG8.L) Q3 2024 Earnings Report

In the third quarter of 2024, Elevance Health Inc reported a revenue of $45.1 billion, reflecting a year-over-year increase of 5.36%. However, the company's profitability faced significant pressure, with net income declining by 21.18% year-over-year to $1.016 billion. Management highlighted ongoing adjustments in operational efficiencies and strategies to navigate a challenging economic environment. The company’s EBITDA of $2.002 billion indicates a robust operational capacity despite recent fluctuations in income metrics.

The results indicate a stronger than expected revenue growth due to increased membership and price adjustments across services even as profit margins contracted significantly. Investors should pay close attention to the strategic measures being implemented to restore profitability as competition intensifies and macroeconomic factors persist.